Happy BioGen-day to those who celebrate
Wild to remember that March 10, 2020, was the Massachusetts declaration of emergency regarding the COVID-19 pandemic (four years ago today!). The federal declaration came a few days later on March 13, 2020.
March 10, 2024 at 1:33 PM
Happy BioGen-day to those who celebrate
Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee
www.fiercepharma.com/marketing/bi...
www.fiercepharma.com/marketing/bi...
Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee
Biogen has teamed with gymnast Suni Lee for a campaign, leveraging the Olympic gold medalist’s health journey and social media audience to vault deeper into kidney health awareness. | Biogen has team...
www.fiercepharma.com
September 24, 2026 at 1:24 PM
Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee
www.fiercepharma.com/marketing/bi...
www.fiercepharma.com/marketing/bi...
Biogen to pay $18.9 million to settle investors' claims over Alzheimer's drug reut.rs/4euk1uV
Biogen to pay $18.9 million to settle investors' claims over Alzheimer's drug
Biogen has agreed to pay $18.9 million to resolve a lawsuit alleging that it misled investors about the commercial readiness of the pharmaceutical company's Alzheimer's disease drug Aduhelm.
reut.rs
June 8, 2026 at 9:25 PM
Biogen to pay $18.9 million to settle investors' claims over Alzheimer's drug reut.rs/4euk1uV
April 20, 2025 at 12:00 PM
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm reut.rs/3IChphi
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm
Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats.
reut.rs
July 21, 2025 at 12:50 PM
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm reut.rs/3IChphi
A pre-JPM Friday firehose of news:
Four biotechs emerge with $800M: endpts.com/four-biotech...
Former top Moderna scientist's new startup: endpts.com/modernas-for...
Obesity drug startup Metsera files IPO: endpts.com/obesity-drug...
Biogen offers to buy partner Sage: endpts.com/biogen-offer...
Four biotechs emerge with $800M: endpts.com/four-biotech...
Former top Moderna scientist's new startup: endpts.com/modernas-for...
Obesity drug startup Metsera files IPO: endpts.com/obesity-drug...
Biogen offers to buy partner Sage: endpts.com/biogen-offer...
Biogen offers to buy out struggling neuro partner Sage Therapeutics
Biogen has made an offer to acquire its partner Sage Therapeutics, according to a Friday evening regulatory disclosure, following months of setbacks by the smaller company that have led to a long slid...
endpts.com
January 11, 2025 at 12:15 AM
A pre-JPM Friday firehose of news:
Four biotechs emerge with $800M: endpts.com/four-biotech...
Former top Moderna scientist's new startup: endpts.com/modernas-for...
Obesity drug startup Metsera files IPO: endpts.com/obesity-drug...
Biogen offers to buy partner Sage: endpts.com/biogen-offer...
Four biotechs emerge with $800M: endpts.com/four-biotech...
Former top Moderna scientist's new startup: endpts.com/modernas-for...
Obesity drug startup Metsera files IPO: endpts.com/obesity-drug...
Biogen offers to buy partner Sage: endpts.com/biogen-offer...
US regulator approves at-home Alzheimer’s drug from Eisai and Biogen on.ft.com/4p6z2GT
US regulator approves at-home version of Alzheimer’s drug Leqembi from Eisai and Biogen
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
on.ft.com
August 29, 2025 at 9:06 PM
US regulator approves at-home Alzheimer’s drug from Eisai and Biogen on.ft.com/4p6z2GT
Italy probes Biogen for allegedly hindering sales of rival's MS drug reut.rs/4dKkW98
Italy probes Biogen for allegedly hindering sales of rival's MS drug
Italy's antitrust authority (AGCM) said on Wednesday it had opened an investigation into Biogen Italia and its U.S. parent Biogen over allegedly trying to prevent rival drugmaker Sandoz from offering a cheaper multiple sclerosis drug.
reut.rs
May 27, 2026 at 11:10 AM
Italy probes Biogen for allegedly hindering sales of rival's MS drug reut.rs/4dKkW98
perfect example: Biogen makes my MS meds. they are "expensive." but Biogen also offers to pay the difference that my insurance doesn't cover through a rebate program
what? how does that work? what's the point?
this or I'm ambulatory.
what? how does that work? what's the point?
this or I'm ambulatory.
December 12, 2025 at 3:36 AM
perfect example: Biogen makes my MS meds. they are "expensive." but Biogen also offers to pay the difference that my insurance doesn't cover through a rebate program
what? how does that work? what's the point?
this or I'm ambulatory.
what? how does that work? what's the point?
this or I'm ambulatory.
@endpts.com scoop: Biogen is cutting staff across its research department, focusing on "the needs of a prioritized preclinical portfolio and a shift of resources to external opportunities," according to a company statement. endpts.com/exclusive-bi...
Exclusive: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’
Biogen is laying off staff across its research unit, marking one of the most concerted strategic decisions from Jane Grogan since she took over the department.
endpts.com
January 22, 2025 at 5:06 PM
@endpts.com scoop: Biogen is cutting staff across its research department, focusing on "the needs of a prioritized preclinical portfolio and a shift of resources to external opportunities," according to a company statement. endpts.com/exclusive-bi...
As already the largest biotech employer in the state, Biogen continues to invest in the future of North Carolina with an additional $2 billion commitment. Thank you for continuing to be a part of our success story.
October 9, 2025 at 5:17 PM
As already the largest biotech employer in the state, Biogen continues to invest in the future of North Carolina with an additional $2 billion commitment. Thank you for continuing to be a part of our success story.
O Globo: Alzheimer: Anvisa aprova novo medicamento para fase inicial da doença oglobo.globo.com/saude/notici...
Alzheimer: Anvisa aprova novo medicamento para fase inicial da doença
Aval foi para o Leqembi, das farmacêuticas Biogen e Eisai, que pertence a uma nova geração de anticorpos e consegue retardar de forma modesta a perda cognitiva
oglobo.globo.com
January 7, 2026 at 9:02 PM
O Globo: Alzheimer: Anvisa aprova novo medicamento para fase inicial da doença oglobo.globo.com/saude/notici...
Biogen to acquire RayThera for $1 billion reut.rs/4oxa0k6
Biogen to acquire RayThera for $1 billion
Biogen said on Wednesday it would acquire drug discovery company RayThera for $1 billion, including milestone payments.
reut.rs
June 17, 2026 at 11:15 PM
Biogen to acquire RayThera for $1 billion reut.rs/4oxa0k6
ANTITRUST
Biogen probed by Italy over MS drug competition
cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews
Biogen probed by Italy over MS drug competition
cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews
Biogen probed by Italy over MS drug competition
Italy probes Biogen over alleged attempts to block Sandoz’s MS biosimilar and limit competition in natalizumab drugs.
cinquewnews.blogspot.com
May 27, 2026 at 7:28 AM
ANTITRUST
Biogen probed by Italy over MS drug competition
cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews
Biogen probed by Italy over MS drug competition
cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews
"According to The Lever’s analysis, three of the four FDA physician advisors on Leqembi had financial conflicts of interest with Biogen, Eisai’s partner in developing the drug, including receiving consulting fees, speaking honoraria, and research funding."
www.levernews.com/the-deadly-s...
www.levernews.com/the-deadly-s...
January 29, 2025 at 7:53 PM
"According to The Lever’s analysis, three of the four FDA physician advisors on Leqembi had financial conflicts of interest with Biogen, Eisai’s partner in developing the drug, including receiving consulting fees, speaking honoraria, and research funding."
www.levernews.com/the-deadly-s...
www.levernews.com/the-deadly-s...
Biogen has announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real estate consolidation plan in Massachusetts.
March 25, 2025 at 3:17 PM
Biogen has announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real estate consolidation plan in Massachusetts.
Biogen to advance experimental Alzheimer’s drug despite mid-stage trial miss reut.rs/4dH3Wlk
Biogen to advance experimental Alzheimer’s drug despite mid-stage trial miss
Biogen will advance its experimental Alzheimer's drug to late-stage development after a mid-stage study showed it slowed mental decline and reduced a key brain protein linked to the disease, although it failed to meet the trial's main goal.
reut.rs
May 14, 2026 at 4:35 PM
Biogen to advance experimental Alzheimer’s drug despite mid-stage trial miss reut.rs/4dH3Wlk
Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial. www.statnews.com/2026/05/21/p...
Closely watched experimental Parkinson’s drug fails key clinical trial
Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial.
www.statnews.com
May 22, 2026 at 2:14 PM
Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial. www.statnews.com/2026/05/21/p...
It’s one that I pulled from a stranger but it has some good stuff.
Dax J - No Redemption
Computer Numerical Control - 502
Regal - Acid is the Answer
Biogen - 160 Techno
Falling Apart - 202 B1
Dax J - No Redemption
Computer Numerical Control - 502
Regal - Acid is the Answer
Biogen - 160 Techno
Falling Apart - 202 B1
September 24, 2026 at 7:12 AM
It’s one that I pulled from a stranger but it has some good stuff.
Dax J - No Redemption
Computer Numerical Control - 502
Regal - Acid is the Answer
Biogen - 160 Techno
Falling Apart - 202 B1
Dax J - No Redemption
Computer Numerical Control - 502
Regal - Acid is the Answer
Biogen - 160 Techno
Falling Apart - 202 B1
Biogen gets FDA approval for higher dose of genetic disorder drug reut.rs/4bLKilS
Biogen gets FDA approval for higher dose of genetic disorder drug
The U.S. Food and Drug Administration has approved a higher dose of Biogen's spinal muscular atrophy drug Spinraza, the company said on Monday, after rejecting it last year.
reut.rs
March 30, 2026 at 4:50 PM
Biogen gets FDA approval for higher dose of genetic disorder drug reut.rs/4bLKilS
🚧 Biogen, an American multinational biotechnology company, has broken ground on its new global headquarters + innovation hub at 75 Broadway in Kendall Square.
The 580,000 square feet campus opens in 2028, coinciding with Biogen’s 50th anniversary.
The 580,000 square feet campus opens in 2028, coinciding with Biogen’s 50th anniversary.
October 16, 2025 at 5:26 PM
🚧 Biogen, an American multinational biotechnology company, has broken ground on its new global headquarters + innovation hub at 75 Broadway in Kendall Square.
The 580,000 square feet campus opens in 2028, coinciding with Biogen’s 50th anniversary.
The 580,000 square feet campus opens in 2028, coinciding with Biogen’s 50th anniversary.